Logo Ente

Strategmed II

StrategmedII

PREVENTION AND TREATMENT OF DISEASES OF CIVILIZATION - STRATEGMED II

The new tools of molecular diagnostics and imaging individualized therapy of breast cancer, thyroid and prostate acronym MILESTONE

The aim of the project is to use decision support tools for the treatment of topical better prognosis of cancer: breast, thyroid, prostate, thereby producing a significant reduction in the aggressiveness of the treatment of oncological and reducing its social and economic costs, without compromising the effectiveness of the therapy. Innovative molecular test will be based on tumor genomics, taking into account the heterogeneity of the weave (material downloaded tumor m. In. Navigation through biopsy).

The term of the project: 01.11.2015 r. - 03.31.2018 r

PROJECT FINANCED BY THE NATIONAL CENTER FOR RESEARCH AND DEVELOPMENT PROGRAMMEN STRATEGMED II